{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-029232","form_type":"8-K","ticker":"ZLAB","cik":"0001704292","company_name":"Zai Lab Ltd","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.766817+00:00","generated_at":"2026-06-22T01:33:23.833612+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Zai Lab Q3 revenue $57.5M (+33% YoY); net loss widens to $161.2M on Seagen payment","bullets":["Total revenues $57.5M vs $43.1M YoY; net product revenue led by ZEJULA $39.2M.","Net loss $161.2M vs $96.4M YoY, reflecting $30M upfront to Seagen and $36.7M FX loss.","Cash & equivalents $1.12B; company expects runway through 2025.","Entered collaboration with Seagen for TIVDAK in Greater China.","Appointed Dr. Peter Huang as CSO and Alette Verbeek as SVP Global Strategic Partnering."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-029232","json":"https://secwatch.observer/filing/0001628280-22-029232.json","markdown":"https://secwatch.observer/filing/0001628280-22-029232.md","text":"https://secwatch.observer/filing/0001628280-22-029232.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704292/000162828022029232/0001628280-22-029232-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704292/000162828022029232/zlab-20221109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T01:33:23.833612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"02a020dca62b921bce001d196dfa04c5282ee1ab","claim":"Zai Lab Ltd reported the three months ended September 30, 2022 results: revenue $57.5 million.","evidence_excerpt":"expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Zai Lab Announces Third Quarter 2022 Financial Results and Corporate Updates – Revenue of $57.5 million for the third quarter of 2022, representing a 33% increase y-o-y and a 19% increase q-o-q; continued revenue growth led by ZEJULA – Regional strategic collaboration for TIVDAK ®","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704292/000162828022029232/0001628280-22-029232-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended September 30, 2022"},{"label":"Revenue","value":"$57.5 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}